← All trials
NCT05384951
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 15, 2022
- Primary completion
- May 31, 2024
- Completion date
- May 31, 2024
- First posted
- May 23, 2022
- Last posted
- Jun 9, 2022
- Enrollment
- 10
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Gillette Children's Specialty HealthcareLead sponsor
- Gillette Children's Specialty HealthcareReponsible party - principal investigator
- University of MinnesotaCollaborator
- Metabolic TechnologiesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.